Immunovant Inc (IMVT) Hedge Fund & Institutional Holdings (Q2 2026)

IMVT ranks #2672 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

IMVT is a top-conviction position for Alpine Global Management, LLC — at 8.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in IMVT belongs to FMR LLC, but the position matters far more to Alpine Global Management, LLC, who has 8.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Farallon Capital Management, L.l.c. has added to its IMVT position for two straight quarters, increasing it by $223.4M to reach $223.7M today.

Armistice Capital, LLC has trimmed its IMVT position for two straight quarters, cutting it by $52.0M while still holding $113.1M.

IMVT is up 0.9% today, and institutions have been net buyers of $222.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

IMVT reported a net loss of $505.6M in its latest fiscal year.

• Not yet profitable — net loss of $505.6M in the latest fiscal year
• Net income declined year over year, from -$413.8M to -$505.6M
• Operating cash flow was negative, using $407.3M in cash
• Current ratio of 9.09x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.12x equity — within a conventional range